论文部分内容阅读
目的浅析联合检测血清降钙素原(PCT)与高敏C-反应蛋白(hs-CRP)对婴儿下呼吸道感染性疾病的诊断价值。方法选取2014年1月至2015年9月下呼吸道感染婴儿65例为实验组,并选择同期体检的健康婴儿65例为对照组,比较两组婴儿体内hs-CRP、PCT含量,及hs-CRP、PCT检测的特异度和灵敏度。结果实验组hs-CRP、PCT含量均高于对照组,且hs-CRP与PCT联合检测的灵敏度[92.31%(60/65)]和特异度[95.39%(62/65)]均高于单项检测,差异均有统计学意义(P<0.05)。结论联合检测hs-CRP和PCT的特异度和灵敏度均较高,可为临床早期合理用药提供依据。
Objective To analyze the diagnostic value of combined detection of serum procalcitonin (PCT) and high-sensitivity C-reactive protein (hs-CRP) in lower respiratory tract infectious diseases in infants. Methods From January 2014 to September 2015, 65 infants with lower respiratory tract infection were selected as the experimental group and 65 healthy infants were selected as the control group. The hs-CRP, PCT content, hs-CRP , Specificity and sensitivity of PCT test. Results The levels of hs-CRP and PCT in the experimental group were higher than those in the control group, and the sensitivity and specificity of combined detection of hs-CRP and PCT were 92.31% (60/65) and 95.39% (62/65), respectively Test, the difference was statistically significant (P <0.05). Conclusions The combined detection of hs-CRP and PCT has high specificity and sensitivity, which can provide a basis for early clinical rational drug use.